Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution

Clinical trial NCT04284514 · COMPLETED

Trial details

NCT number: NCT04284514
Sponsor: Aerpio Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ocular Hypertension Primary Open Angle Glaucoma

Start date: 2019-05-02
Primary completion: 2019-12-15
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.